Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,121 | 125,563 | 122,311 | 137,142 | 169,236 |
| Marketable Securities | 1,966 | 3,499 | 5,048 | 6,338 | 2,029 |
| Receivables | 83,659 | 73,482 | 64,399 | 35,942 | 48,054 |
| Inventories | 14,661 | 17,979 | 17,262 | 22,163 | 12,722 |
| Income taxes - deferred | 1,735 | 7,209 | 7,082 | 6,743 | 2,638 |
| TOTAL | $254,418 | $236,765 | $223,844 | $216,203 | $243,493 |
| Non-Current Assets | |||||
| PPE Net | 208,973 | 188,245 | 172,481 | 157,963 | 152,701 |
| Intangibles | 5,502 | 5,502 | 5,029 | 5,029 | 5,029 |
| Other Non-Current Assets | 77,971 | 82,450 | 92,630 | 92,082 | 99,096 |
| TOTAL | $292,446 | $276,197 | $270,140 | $255,074 | $256,826 |
| Total Assets | $546,864 | $512,962 | $493,984 | $471,277 | $500,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,360 | 4,920 | 10,229 | 16,927 | 17,187 |
| Accounts payable and accrued liabilities | 40,530 | 33,902 | 32,182 | 24,034 | 25,409 |
| Accrued Expenses | 22,054 | 15,885 | 15,023 | 14,944 | 25,284 |
| Other current liabilities | 1,748 | 9,865 | 9,734 | 9,113 | N/A |
| TOTAL | $71,054 | $68,931 | $72,504 | $70,934 | $75,719 |
| Non-Current Liabilities | |||||
| Long Term Debt | 54,094 | 48,873 | 29,074 | 29,657 | 30,239 |
| Deferred Revenues | 1,362 | 4,359 | 5,336 | 5,916 | 7,839 |
| Other Non-Current Liabilities | 6,746 | 9,560 | 9,910 | 9,716 | 18,773 |
| TOTAL | $59,083 | $59,528 | $40,250 | $41,420 | $51,039 |
| Total Liabilities | $130,137 | $128,459 | $112,754 | $112,354 | $126,758 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,015 | 35,953 | 35,851 | 35,508 | 35,128 |
| Common Shares | 36 | 36 | 36 | 35 | 35 |
| Retained earnings | 196,869 | 168,212 | 166,663 | 152,453 | 173,850 |
| Other shareholders' equity | -832 | 317 | 1,211 | 2,068 | 1,987 |
| TOTAL | $416,727 | $384,503 | $381,230 | $358,923 | $373,561 |
| Total Liabilities And Equity | $546,864 | $512,962 | $493,984 | $471,277 | $500,319 |